LS
Lmh Strategic Solutions
OtherLobbying firm/org/lmh-strategic-solutions
Clients reported · 2025
21
Reported income · 2025
$910K
Issue areas
3
Clients
Organizations represented in 2025.
AAlkermesSince Jan 2026 · MMM$90KAPAlnylam PharmaceuticalsSince Jan 2026 · MMM$70KIIncyteSince Jan 2026 · MMM, PHA$70KAPAvadel PharmaceuticalsSince Jan 2026 · PHA$60KIPIonis PharmaceuticalsSince Jan 2026 · HCR$60KRRegenxbioSince Jan 2026 · MMM, PHA$60KGGlaxosmithklineSince Jan 2026 · HCR, PHA$50KNNeuroPaceSince Jan 2026 · MMM$50KPTPtc TherapeuticsSince Jan 2026 · HCR$50KAPAcadia PharmaceuticalsSince Jan 2026 · MMM, PHA$30KAArdelyxSince Jan 2026 · MMM, PHA$30KBPBiomarin PharmaceuticalSince Jan 2026 · MMM, PHA$30KEIErisa Industry Committee (eric)Since Jan 2026 · HCR$30KEExelixisSince Jan 2026 · MMM, PHA$30KHBHarmony BiosciencesSince Jan 2026 · MMM, PHA$30KNBNeurocrine BiosciencesSince Jan 2026 · MMM, PHA$30KPRPharmaceutical Research and Manufacturers of America (PhRMA)Since Jan 2026 · MMM, PHA$30KSSavaraSince Jan 2026 · MMM, PHA$30KSBStealth BiotherapeuticsSince Jan 2026 · HCR$30KTTTravere TherapeuticsSince Jan 2026 · PHA$30KMDMedical Device Manufacturers Association (MDMA)Since Jan 2026 · HCR$20K
Activity
No recent organization activity yet. Historical comments remain available in the record.